2177GCCC:ID'Ing tx Targets and Biomarkers for Ocular Surface Disease in Pt w/ oGVHD
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Maryland, Baltimore
About this trial
Evaluate and study the immunologic changes to the ocular surface in cancer patients.
Eligibility criteria
Qualifiers
Adult patients (≥ 18 years of age) who visit the Eye clinic either in the UMGCCC within the UMD Hospital or the UMD Faculty Physicians Ophthalmology Practice at the UMD Professional Building or satellite locations for initial visits or established visits.
The patient must be able to understand and sign and date the informed consent form approved by the IRB.
Disqualifiers
Vulnerable populations: neonates, children, prisoners, institutionalized individuals.
Inability or refusal to provide informed consent.
History of ocular surgery (except refractive surgery or cataract surgery)
Trial design
Treatments tested in this trial
- The standard care exam and biological specimens' collection
Treatment groups
150 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov